Literature DB >> 7593783

International summit on cutaneous antifungal therapy. Boston, Massachusetts, Nov. 11-13, 1994.

B Elewski1, R J Hay.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1995        PMID： 7593783     DOI： 10.1016/0190-9622(95)91838-8

Source DB:  PubMed          Journal:  J Am Acad Dermatol        ISSN： 0190-9622            Impact factor:   11.527


× No keyword cloud information.
  6 in total

1.  [Hyperhidrosis as risk factor for tinea pedis].

Authors:  I Boboschko; S Jockenhöfer; R Sinkgraven; B Rzany
Journal:  Hautarzt       Date:  2005-02       Impact factor: 0.751

Review 2.  [Influence of nutrition, common autoimmune diseases and smoking on the incidence of foot mycoses].

Authors:  G Daeschlein; L Rauch; H Haase; A Arnold; S Lutze; S von Podewils; M Niggemeier; M Jünger
Journal:  Hautarzt       Date:  2019-08       Impact factor: 0.751

3.  Rapid discrimination among dermatophytes, Scytalidium spp., and other fungi with a PCR-restriction fragment length polymorphism ribotyping method.

Authors:  M Machouart-Dubach; C Lacroix; M F de Chauvin ; I Le Gall ; C Giudicelli; F Lorenzo; F Derouin
Journal:  J Clin Microbiol       Date:  2001-02       Impact factor: 5.948

Review 4.  A risk-benefit assessment of the newer oral antifungal agents used to treat onychomycosis.

Authors:  A K Gupta; N H Shear
Journal:  Drug Saf       Date:  2000-01       Impact factor: 5.606

Review 5.  Current management of fungal infections.

Authors:  J F Meis; P E Verweij
Journal:  Drugs       Date:  2001       Impact factor: 9.546

6.  High prevalence of skin diseases and need for treatment in a middle-aged population. A Northern Finland Birth Cohort 1966 study.

Authors:  Suvi-Päivikki Sinikumpu; Laura Huilaja; Jari Jokelainen; Markku Koiranen; Juha Auvinen; Päivi M Hägg; Erika Wikström; Markku Timonen; Kaisa Tasanen
Journal:  PLoS One       Date:  2014-06-09       Impact factor: 3.240
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.